Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Mechanism of Action of Colchicine in the Treatment of Gout
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Clarification concerning amoxicillin skin testing
Fatty acids, inflammation, and asthma
Defects of class-switch recombination
Regulation of inflammasomes by autophagy
Laurent L'homme, PhD, David Dombrowicz, PhD 
Therapy of autoinflammatory syndromes
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi.
A crystal-clear mechanism of chronic kidney disease
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses  Raphaela Goldbach-Mansky, MD,
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Thomas F. Tedder, PhD, Takashi Matsushita, MD, PhD 
Fatty acids, inflammation, and asthma
TNF-α–induced protein 3 (A20): The immunological rheostat
Rising prevalence of asthma is sex-specific in a US farming population
David J. Cousins, PhD, Joanne McDonald, BSc, Tak H. Lee, MD, ScD 
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Unraveling the NALP-3/IL-1β Inflammasome
MicroRNAs: Essential players in the regulation of inflammation
Effects of air pollutants on innate immunity: The role of Toll-like receptors and nucleotide-binding oligomerization domain–like receptors  Rebecca N.
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
1. Overview of the human immune response
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Larisa I. Labzin, PhD, Mario A.R. Lauterbach, MSc, Eicke Latz, MD, PhD 
Manfred Fliegauf, PhD, Bodo Grimbacher, MD 
News Beyond Our Pages Journal of Allergy and Clinical Immunology
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Karin R. Engelhardt, Dr rer nat, Bodo Grimbacher, MD 
What is an “eosinophilic phenotype” of asthma?
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
New pathways for itching in patients with atopic dermatitis?
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Innate immunity Journal of Allergy and Clinical Immunology
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
TH9 immunodeficiency in patients with hyper-IgE syndrome
Innate immune responses to infection
Endotoxin and the lung: Insight into the host-environment interaction
Measles and immunomodulation
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Environmental factors and eosinophilic esophagitis
Kinase inhibitors in clinical practice: An expanding world
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010  Scott H. Sicherer, MD, Donald Y.M.
Primary prevention of asthma and allergy
Itching as a systemic disease
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Presentation transcript:

Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells Balaji Banoth, PhD, Suzanne L. Cassel, MD  Journal of Allergy and Clinical Immunology  Volume 140, Issue 4, Pages 985-987 (October 2017) DOI: 10.1016/j.jaci.2017.03.041 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 BTK-mediated regulation of NLRP3 inflammasome complex activation. Toll-like receptor (TLR) signaling primes the NLRP3 inflammasome for activation and upregulates NLRP3 and ILIB mRNA. During NLRP3 inflammasome activation, BTK is activated through phosphorylation at tyrosine 551 and physically interacts with the NLRP3 inflammasome components NLRP3 and ASC. Interference with BTK, whether through mutation or chemical inhibition, results in failure of NLRP3 inflammasome activation with loss of IL-1β secretion and caspase-1 activation, showing BTK is necessary for NLRP3 inflammasome activation in patients. CARD, Caspase activation and recruitment domain; LRR, leucine rich repeat; NACHT, nucleotide binding and oligomerization domain; NF-κB, nuclear factor κB. Journal of Allergy and Clinical Immunology 2017 140, 985-987DOI: (10.1016/j.jaci.2017.03.041) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions